Skip to main content
logo
Profound Medical Corp. (PROF)
NASDAQ: PROF · Real-Time Price · USD
6.65
+0.06 (0.91%)
Jun 30, 2026, 4:00 PM EDT - Market closed

Profound Medical Income Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
18.8116.110.687.26.686.87
Revenue Growth (YoY)
58.61%50.73%48.35%7.75%-2.79%-5.90%
Cost of Revenue
5.444.713.642.893.663.92
Gross Profit
13.3711.397.044.313.022.95
Selling, General & Admin
30.4332.0523.1318.5417.9317.97
Research & Development
21.0520.616.9714.4214.6915.28
Other Operating Expenses
----2.52-
Total Operating Expenses
51.4852.6540.132.9635.1533.24
Operating Income
-38.11-41.25-33.06-28.65-32.13-30.29
Total Non-Operating Income (Expense)
-0.56-1.065.240.23.74-0.3
Pretax Income
-38.66-42.32-27.82-28.45-28.38-30.59
Provision for Income Taxes
0.240.25-0-0.13-0.11
Net Income
-38.9-42.57-27.82-28.32-28.67-30.7
Net Income to Common
-38.9-42.57-27.82-28.32-28.67-30.7
Shares Outstanding (Basic)
323025212120
Shares Outstanding (Diluted)
323025212120
Shares Change (YoY)
21.37%22.08%16.91%1.69%1.79%18.33%
EPS (Basic)
1.241.411.121.341.381.50
EPS (Diluted)
1.241.411.121.341.381.50
EPS Growth
1.64%25.89%-16.42%-2.90%-8.00%20.00%
Free Cash Flow
-38.51-38.38-23.45-22.61-25.8-22.39
Free Cash Flow Per Share
-1.21-1.27-0.95-1.07-1.24-1.09
Gross Margin
71.07%70.77%65.89%59.90%45.22%42.95%
Operating Margin
-202.56%-256.27%-309.57%-397.99%-480.86%-440.73%
Profit Margin
-206.76%-264.44%-260.45%-393.43%-429.11%-446.66%
FCF Margin
-204.67%-238.43%-219.60%-314.06%-386.17%-325.80%
EBITDA
-37.61-40.69-32.13-27.72-30.52-28.41
EBITDA Margin
-199.91%-252.79%-300.81%-385.08%-456.85%-413.39%
EBIT
-38.11-41.25-33.06-28.65-32.13-30.29
EBIT Margin
-202.56%-256.27%-309.57%-397.99%-480.86%-440.73%
Effective Tax Rate
-0.61%-0.60%0.01%0.45%0.00%-0.34%
SEC Filings: 10-K · 10-Q